Skip to main content
Clinical Trials/NCT04472520
NCT04472520
Withdrawn
Not Applicable

Use of AliveCor ECG Monitoring to Replicate ECG Lead Recording

Mayo Clinic1 site in 1 countryJanuary 1, 2021
ConditionsArrhythmia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arrhythmia
Sponsor
Mayo Clinic
Locations
1
Primary Endpoint
Electrocardiogram (ECG) QT Interval
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

The researchers are trying to determine whether the Alivecor device can simulate other electrocardiogram (ECG) leads to record electrical activity.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 31, 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dan Sorajja

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Individuals greater than 18 years old getting an ECG

Exclusion Criteria

  • Patients unwilling or unable to provide informed consent

Outcomes

Primary Outcomes

Electrocardiogram (ECG) QT Interval

Time Frame: 1 day

The QT interval represents the time of ventricular activity including both depolarization and repolarization. It is measured from the beginning of the QRS complex to the end of the T wave. Normally, the QT interval is 0.36 to 0.44 seconds

Study Sites (1)

Loading locations...

Similar Trials